Patents by Inventor Earl C. Goyarts

Earl C. Goyarts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090196942
    Abstract: Topical skin care composition comprising an extract of Citrus Jabara, topical compositions having anti-histamine activity, and methods and regimens for treating skin with compositions containing an extract of Citrus Jabara.
    Type: Application
    Filed: February 1, 2008
    Publication date: August 6, 2009
    Inventors: Earl C. Goyarts, Thomas Mammone, Alaine Ranieri-Chamberlain, Ashraf Shokralla
  • Patent number: 7510734
    Abstract: The present invention relates to a method of stimulating beta-defensins in skin cells which comprises applying to the skin cells an effective amount of a Lactobacillus extract or active fraction thereof.
    Type: Grant
    Filed: March 2, 2005
    Date of Patent: March 31, 2009
    Assignee: E-L Management Corporation
    Inventors: Michael Sullivan, Steven F. Schnittger, Thomas Mammone, Earl C. Goyarts
  • Patent number: 6531140
    Abstract: The present invention relates to cosmetic or pharmaceutical topical compositions containing at least one cyclic nucleotide having its 2′ hydroxyl group replaced by a hydrogen atom for inhibiting phosphodiesterase activity. The phosphodiesterase inhibitor is in combination with a magnesium buffer and a cosmetically or pharmaceutically acceptable carrier. The invention also includes methods for treating or preventing inflammation or irritation such as is common in the skin disease, atopic dermatitis, which is known to be related to the uncontrolled activity of phosphodiesterase.
    Type: Grant
    Filed: May 4, 1999
    Date of Patent: March 11, 2003
    Assignee: E-L Management
    Inventors: Thomas Mammone, Earl C. Goyarts, Neelam Muizzuddin
  • Publication number: 20020090384
    Abstract: The present invention relates to cosmetic or pharmaceutical topical compositions containing at least one cyclic nucleotide having its 2′ hydroxyl group replaced by a hydrogen atom for inhibiting phosphodiesterase activity. The phosphodiesterase inhibitor is in combination with a magnesium buffer and a cosmetically or pharmaceutically acceptable carrier. The invention also includes methods for treating or preventing inflammation or irritation such as is common in the skin disease, atopic dermatitis, which is known to be related to the uncontrolled activity of phosphodiesterase.
    Type: Application
    Filed: May 4, 1999
    Publication date: July 11, 2002
    Inventors: THOMAS MAMMONE, EARL C. GOYARTS, NEELAM MUIZZUDDIN